Oxford BioDynamics Plc
OTC: OXBOF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Iain Gladstone Ross
- Employees
- 51
- Headquarters
- Oxford, United Kingdom
- IPO year
- 2020
- Market cap
- $6.4M
- Website
- https://www.oxfordbiodynamics.com
Loading OXBOF…
Loading profile data…Frequently asked questions about OXBOF
What does Oxford BioDynamics Plc (OXBOF) do?
Headquartered in Oxford, United Kingdom, and established in 2007, Oxford BioDynamics Plc operates as a biotechnology enterprise. The company's primary focus lies in the discovery and development of biomarkers for the pharmaceutical and biotechnology industries, serving both domestic and international markets, with a significant presence in the U...
Where does OXBOF trade?
Oxford BioDynamics Plc (OXBOF) trades on the Other OTC.
What sector is OXBOF in?
Oxford BioDynamics Plc (OXBOF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Oxford BioDynamics Plc?
Iain Gladstone Ross is the chief executive officer of Oxford BioDynamics Plc (OXBOF).
Where is Oxford BioDynamics Plc headquartered?
Oxford BioDynamics Plc is headquartered in United Kingdom.
Does OXBOF pay a dividend?
Oxford BioDynamics Plc (OXBOF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did OXBOF go public?
Oxford BioDynamics Plc (OXBOF) completed its initial public offering in 2020.